AbbVie Inc (ABBV)

ABBV (NYSE:Drugs) EQUITY
$52.58
pos +0.00
+0.00%
Today's Range: 51.60 - 52.97 | ABBV Avg Daily Volume: 8,966,800
Last Update: 02/12/16 - 4:01 PM EST
Volume: 0
YTD Performance: -11.24%
Open: $0.00
Previous Close: $52.18
52 Week Range: $45.45 - $71.60
Oustanding Shares: 1,634,746,917
Market Cap: 85,301,094,129
6-Month Chart
TheStreet Ratings Grade for ABBV
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 10
Moderate Buy 1 1 1 1
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.38 1.38 1.21
Latest Dividend: 0.57
Latest Dividend Yield: 4.37%
Dividend Ex-Date: 01/13/16
Price Earnings Ratio: 12.16
Price Earnings Comparisons:
ABBV Sector Avg. S&P 500
12.16 16.60 26.86
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-12.70% -7.84% 48.45%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.20 0.24 0.07
Net Income 190.00 -0.02 -0.01
EPS 185.20 -0.06 -0.02
Earnings for ABBV:
EBITDA 7.54B
Revenue 22.86B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $1.11 $1.22 $5.06 $6.02
Number of Analysts 6 4 10 9
High Estimate $1.15 $1.24 $5.10 $6.32
Low Estimate $1.03 $1.21 $5.01 $5.75
Prior Year $0.94 $1.08 $4.29 $5.06
Growth Rate (Year over Year) 18.09% 12.96% 17.95% 18.88%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
The electrics have been crackling, but the group has more downside risk than currently perceived.
They offer impressive free cash flow, great balance sheets, evolving pipelines and nice dividend yields.

Stocks Continue to Sink Real Money Pro($)

The market's major indices are getting worse as the morning progresses.
In a year's time, investors may look back and think this was a great entry point.
Celgene, AbbVie and Gilead are set to report earnings. Here's what to look for.
The year has not started the way most pundits and prognosticators had envisioned.
Each of these small-caps delivered good news recently, only to have their stocks decline.
Each of these small-caps delivered good news recently, only to have their stocks decline.
It was all about the FANGs in 2015, but go for value plays this year.
Look for market leadership to shift as the U.S. economy plods along.

Columnist Conversations

I respectfully disagree. Scalia's passing will likely have little impact on the electorate or on a partisan Wa...
All; I've received a few questions about the subject of my column for this weekend about the implications of a...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.